Combined Use of Naldebain® ER Injection and Precedex® After VATS
Unknown statusPhase 4NCT06176222
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to investigate the effects of combined use of Naldebain® ER Injection and Precedex® in patients received video-assisted thoracoscopic surgery. The main questions it aims to answer are: * the pain intensity after surgery * the level of dizziness after surgery Participants will receice ultrasound-guided thoracic paravertebral nerve block, intramuscular Naldebain® ER injection and intravenous Precedex® infusion. If there is a comparison group: Researchers will compare experimental group with placebo group to see if pain and dizziness after surgery can reduced.
Study details
- Official title
- To Investigate the Effects of Combined Use of Naldebain® ER Injection and Precedex® After Video-assisted Thoracoscopic Surgery
- Conditions
- Acute Post Operative Pain
- Chronic Post Operative Pain
- Postoperative Complications
- Interventions
- Drug: PRECEDEX INJ★ 2ML
- Drug: Normal saline
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start date
- 2023-12-28
- Primary completion
- 2025-12-31
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Taiwan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Subject's age: 18\~65 years old 2. ASA classification: I\~III Exclusion Criteria: 3. Patients who need postoperative pain relief due to thoracoscopic surgery Exclusion Criteria: 1. The patient suffers from a communication disorder 2. The patient has coagulopathy 3. Sick with obvious heart, lung, liver or kidney disease 4. The patient's body mass index is less than 18.5 or greater than 35 5. Pregnant patients 6. Patients who took opioids for more than three weeks before surgery 7. Patients with contraindications to local anesthesia 8. Patients with a history of chronic pain 9. Patients with a history of drug allergy to Naldebain® ER Injection, COX2-inhibitor NSAIDs (such as parecoxib), or Precedex®
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06176222